Recent News

• 06.05.2025 - Protagonist at the Jefferies Global Healthcare Conference
• 06.02.2025 - Post-ASCO Update: Phase 3 VERIFY Study Results
• 05.21.2025 - Jefferies Global Healthcare Conference
• 04.23.2025 - Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025
• 03.18.2025 - Protagonist Therapeutics Is One of Fast Company’s Most Innovative Companies of 2025

Recent Filings

• 05.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.06.2025 - 8-K Current report
• 05.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.06.2025 - EX-99.1 EX-99.1
• 04.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.29.2025 - ARS Annual Report to Security Holders
• 04.29.2025 - DEF 14A Other definitive proxy statements
• 04.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.23.2025 - 4 Statement of changes in beneficial ownership of securities